Bicocca Open Archive

Logo unimib boa
CONTER, VALENTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.602
EU - Europa 1.100
AS - Asia 295
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 4
OC - Oceania 2
Totale 4.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.573
IT - Italia 226
SE - Svezia 213
DE - Germania 188
IE - Irlanda 146
CN - Cina 143
RU - Federazione Russa 75
GB - Regno Unito 50
AT - Austria 41
HK - Hong Kong 41
UA - Ucraina 36
SG - Singapore 35
VN - Vietnam 32
FI - Finlandia 30
FR - Francia 29
CA - Canada 25
DK - Danimarca 18
TR - Turchia 15
BE - Belgio 12
IN - India 10
ID - Indonesia 7
AR - Argentina 6
EU - Europa 6
NL - Olanda 6
BR - Brasile 5
KR - Corea 5
PL - Polonia 5
ES - Italia 4
GR - Grecia 4
RO - Romania 4
CH - Svizzera 3
GT - Guatemala 3
NO - Norvegia 3
AU - Australia 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IR - Iran 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
IL - Israele 1
JP - Giappone 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 4.024
Salva come PNG Salva come JPEG
Città #
Ann Arbor 677
Fairfield 242
Chandler 219
Woodbridge 171
Wilmington 168
Ashburn 150
Dublin 145
Frankfurt am Main 140
Houston 137
Seattle 107
Cambridge 89
Dearborn 86
New York 82
Milan 68
Princeton 52
Jacksonville 43
Hong Kong 41
Vienna 41
Nanjing 32
Altamura 28
Lawrence 26
Singapore 23
Shanghai 21
Grafing 20
Rome 20
Helsinki 19
Dong Ket 15
San Diego 15
Beijing 14
Boardman 13
Guangzhou 13
Nanchang 10
Brussels 9
Lissone 8
Sulmona 8
Toronto 8
Andover 7
Jakarta 7
London 7
Mountain View 7
Perugia 7
Shenyang 7
Chicago 6
Kunming 6
Lachine 6
Ottawa 6
Paris 6
Bonndorf 5
Edmonton 5
Besana In Brianza 4
Changsha 4
Hangzhou 4
Jinan 4
Monza 4
Zhengzhou 4
Athens 3
Buenos Aires 3
Catania 3
Desio 3
Edinburgh 3
Gaithersburg 3
Gap 3
Hebei 3
Hefei 3
Leawood 3
Norwalk 3
Oslo 3
Pune 3
Redmond 3
Rho 3
Tianjin 3
Warsaw 3
Belo Horizonte 2
Bologna 2
Brasília 2
Brno 2
Campobasso 2
Cedar Knolls 2
Cinisello Balsamo 2
Copperas Cove 2
Daejeon 2
El Salvador 2
Este 2
Fort Worth 2
Fuzhou 2
Istanbul 2
Kraków 2
Merate 2
Ningbo 2
Nürnberg 2
Oviedo 2
Palermo 2
Patti 2
Philadelphia 2
San Jose 2
Sofia 2
Stockholm 2
Tappahannock 2
Turin 2
Verona 2
Totale 3.173
Salva come PNG Salva come JPEG
Nome #
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 261
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 225
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 217
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 208
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 190
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 188
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 177
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 171
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 170
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 169
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 161
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 160
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 150
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 143
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 141
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 139
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 137
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 135
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia 122
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 120
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 118
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia 111
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study 104
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia 99
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 85
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study 81
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 48
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 48
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 34
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 34
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the Methodology 30
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 25
Totale 4.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 75 44 33 63 64 87 86 50 58 64 44 14
2020/2021884 54 99 95 74 47 89 75 89 61 53 68 80
2021/2022484 51 55 66 44 23 52 15 23 35 20 42 58
2022/2023867 88 262 50 85 46 132 15 77 53 2 47 10
2023/2024516 26 16 24 60 64 129 107 26 13 6 5 40
2024/202541 41 0 0 0 0 0 0 0 0 0 0 0
Totale 4.201